683 Capital Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.73M | Sell |
254,000
-51,000
| -17% | -$1.35M | 0.44% | 47 |
|
|
2025
Q1 | $7.37M | Buy |
305,000
+25,000
| +9% | +$604K | 0.51% | 46 |
|
|
2024
Q4 | $11.3M | Sell |
280,000
-40,000
| -13% | -$1.61M | 0.7% | 28 |
|
|
2024
Q3 | $20.3M | Sell |
320,000
-20,000
| -6% | -$1.27M | 1.54% | 12 |
|
|
2024
Q2 | $18M | Sell |
340,000
-15,000
| -4% | -$795K | 1.36% | 15 |
|
|
2024
Q1 | $29.1M | Sell |
355,000
-265,000
| -43% | -$21.7M | 2.13% | 8 |
|
|
2023
Q4 | $11.5M | Sell |
620,000
-5,000
| -0.8% | -$93.1K | 0.95% | 37 |
|
|
2023
Q3 | $6.92M | Buy |
625,000
+45,000
| +8% | +$498K | 0.54% | 48 |
|
|
2023
Q2 | $9.4M | Hold |
580,000
| – | – | 0.68% | 35 |
|
|
2023
Q1 | $9.66M | Buy |
580,000
+551,000
| +1,900% | +$9.17M | 0.72% | 35 |
|
|
2022
Q4 | $273K | Buy |
+29,000
| New | +$273K | 0.02% | 128 |
|